Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kate Watkins, Professor of Cognitive Neuroscience in the Department of Experimental Psychology is the inaugural co-Editor-in-Chief of a new open access journal: the Neurobiology of Language.

Neurobiology of Language is a new open access, peer reviewed journal, which will publish interdisciplinary articles on the neurobiological basis of speech and language. It has been sponsored by the Society of Neurobiology and MIT Press. The Department of Experimental Psychology’s Prof Kate E Watkins, along with Prof Steven L Small of the University of Texas at Dallas are serving as the opening Editors-in-Chief.

Understanding the basis of speech and language presents fascinating new opportunities in cognitive sciences, and this new journal will work on expanding these frontiers. By serving as an outlet for the exchange of important findings, both positive and negative. The journal will be operating a system of “registered reports”, or submissions consisting of only the introduction and detailed methods prior to data collection will be reviewed and considered, thereby leading to more robust research findings across the field of study. As well as primarily publishing research articles, this new journal will also be publishing reviews and perspectives, and all content will be freely available to researchers across the globe.

Read more (Department of Experimental Psychology website)

Similar stories

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.